Evidence map›Paper›PMID 31396392›Full record

ArticleFungal biology and biotechnology2019

A closer look at

Roman P Jansen, Carina Beuck, Matthias Moch, Bianca Klein, Kira Küsters, Holger Morschett, Wolfgang Wiechert, Marco Oldiges

Abstract read
In one paragraph

Article in Fungal biology and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Roman P Jansen1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.
Carina Beuck1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.
Matthias Moch1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.
Bianca Klein1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.
Kira Küsters1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.
Holger Morschett1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.
Wolfgang Wiechert1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.
Marco Oldiges1Forschungszentrum Jülich, Institute of Bio- and Geosciences-Biotechnology (IBG-1), Jülich, Germany.ORCID 0000-0003-0704-5597

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFilamentously growing microorganisms offer unique advantages for biotechnological processes, such as extraordinary secretion capacities, going along with multiple obstacles due to their complex morphology. However, limited experimental throughput in bioprocess development still hampers taking advantage of their full potential. Miniaturization and automation are powerful tools to accelerate bioprocess development, but so far the application of such technologies has mainly been focused on non-filamentous systems. During cultivation, filamentous fungi can undergo remarkable morphological changes, creating challenging cultivation conditions. Depending on the process and product, only one specific state of morphology may be advantageous to achieve e.g. optimal productivity or yield. Different approaches to control morphology have been investigated, such as microparticle enhanced cultivation. However, the addition of solid microparticles impedes the optical measurements typically used by microbioreactor systems and thus alternatives are needed.

results

conclusionA robust workflow for

Indexed as

Antifungal proteinAspergillus giganteusHigh throughput bioprocess developmentMicrotiter plateMiniaturized cultivationMorphology engineeringOnline monitoring

Identifiers

PMID31396392
PMCPMC6681481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.